Form 4: DocuSign Director Anna Marrs Reports Stock Transactions

DocuSign Director Anna Marrs reported the acquisition of shares from RSU vesting and a subsequent sale of common stock under a pre-arranged 10b5-1 plan.

Summary

• Anna Marrs, a Director at DocuSign, Inc. (DOCU), reported recent transactions involving the company's common stock.
• On November 29, 2025, Marrs acquired 729 shares of DocuSign common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Following this acquisition, her direct beneficial ownership of common stock increased to 11,528 shares.
• On December 2, 2025, Marrs sold 365 shares of DocuSign common stock at a price of $68.54 per share.
• This sale was conducted pursuant to a pre-arranged Rule 10b5-1 trading plan.
• After the sale, Marrs' direct beneficial ownership of common stock stands at 11,163 shares.
• She also holds 1,458 Restricted Stock Units (RSUs) which represent a contingent right to receive one share of common stock each.
• The RSUs have a vest commencement date of May 29, 2025, and will vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual meeting or the one-year anniversary of the grant, subject to continued service.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions, including the vesting of Restricted Stock Units (RSUs) and a subsequent sale of a portion of the acquired shares under a pre-arranged 10b5-1 trading plan. These are expected events related to executive compensation and personal financial planning, rather than a strong signal of management's sentiment about the company's immediate prospects. The net effect is a slight reduction in direct beneficial ownership after the vesting and sale.

Positives

• Acquisition of 729 shares through RSU vesting indicates continued equity participation by a director.

Negatives

• Sale of 365 shares by a director, although part of a 10b5-1 plan, reduces direct ownership.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction report.

Industry Context

This filing pertains to routine insider transactions and does not provide information related to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Provides transparency into director's equity holdings and transactions, which can be a factor in investment decisions. The sale under a 10b5-1 plan suggests a pre-planned financial move rather than a reaction to new company information.
• Employees: The RSU vesting is a standard form of equity compensation, aligning director interests with long-term company performance.

Next Steps

• Future vesting of remaining 1,458 Restricted Stock Units (RSUs) in equal quarterly installments over one year from May 29, 2025.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, specifically the vesting of Restricted Stock Units (RSUs) and a subsequent sale of a portion of those shares under a pre-arranged 10b5-1 plan. Such transactions are typically part of an executive's compensation and personal financial management strategy and do not usually signal a change in the company's fundamental outlook or performance. Therefore, based solely on this filing, there is no new information to warrant a change from a "hold" recommendation. Investors should look to broader financial reports and company news for more substantive insights.

Keywords

DocuSign, DOCU, Anna Marrs, Form 4, Insider Trading, Stock Sale, RSU Vesting, 10b5-1 Plan, Director Transactions, Equity Compensation